Literature DB >> 30915606

Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol.

Shuai Liu1,2, Long Li1,2, Lingbing Tan1,2, Xiaozhen Liang3.   

Abstract

Honokiol is a pleiotropic natural compound isolated from Magnolia and has multiple biological and clinically relevant effects, including anticancer and antimicrobial function. However, the antiviral activity of honokiol has not yet been well studied. Here we showed that honokiol had no effect on herpes simplex virus-1 (HSV-1) entry, but inhibited HSV-1 viral DNA replication, gene expression and the production of new progeny viruses. The combination of honokiol and clinical drug acyclovir augmented inhibition of HSV-1 infection. Our results illustrate that honokiol could be a potential new candidate for clinical consideration in the treatment of HSV-1 infection alone or combination with other therapeutics.

Entities:  

Keywords:  Acyclovir; Anti-viral activity; Herpes simplex virus-1 (HSV-1); Honokiol; Viral replication

Mesh:

Substances:

Year:  2019        PMID: 30915606      PMCID: PMC6599498          DOI: 10.1007/s12250-019-00104-5

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  39 in total

1.  The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark.

Authors:  H Kuribara; E Kishi; N Hattori; M Okada; Y Maruyama
Journal:  J Pharm Pharmacol       Date:  2000-11       Impact factor: 3.765

2.  Facile purification of honokiol and its antiviral and cytotoxic properties.

Authors:  Franck Amblard; David Delinsky; Jack L Arbiser; Raymond F Schinazi
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

3.  Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice.

Authors:  H Kuribara; W B Stavinoha; Y Maruyama
Journal:  J Pharm Pharmacol       Date:  1999-01       Impact factor: 3.765

4.  Antifungal activity of magnolol and honokiol.

Authors:  K H Bang; Y K Kim; B S Min; M K Na; Y H Rhee; J P Lee; K H Bae
Journal:  Arch Pharm Res       Date:  2000-02       Impact factor: 4.946

5.  Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.

Authors:  Katsumi Shigemura; Jack L Arbiser; Shi-Yong Sun; Majd Zayzafoon; Peter A S Johnstone; Masato Fujisawa; Akinobu Gotoh; Babette Weksler; Haiyen E Zhau; Leland W K Chung
Journal:  Cancer       Date:  2007-04-01       Impact factor: 6.860

6.  Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.

Authors:  Jeffry J Leary; Robert Wittrock; Robert T Sarisky; Adriana Weinberg; Myron J Levin
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

7.  In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp.

Authors:  Junho Park; Jongsung Lee; Eunsun Jung; Yumi Park; Kukhyun Kim; Byunghwa Park; Kwangseon Jung; Eunkyung Park; Jieun Kim; Deokhoon Park
Journal:  Eur J Pharmacol       Date:  2004-08-02       Impact factor: 4.432

8.  Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo.

Authors:  Xianhe Bai; Francesca Cerimele; Masuko Ushio-Fukai; Muhammad Waqas; Paul M Campbell; Baskaran Govindarajan; Channing J Der; Traci Battle; David A Frank; Keqiang Ye; Emma Murad; Wolfgang Dubiel; Gerald Soff; Jack L Arbiser
Journal:  J Biol Chem       Date:  2003-06-19       Impact factor: 5.157

9.  The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production.

Authors:  Kuo-Tong Liou; Yuh-Chiang Shen; Chieh-Fu Chen; Cheng-Ming Tsao; Shen-Kou Tsai
Journal:  Eur J Pharmacol       Date:  2003-08-15       Impact factor: 4.432

10.  Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs.

Authors:  Emily L C Tan; Eng Eong Ooi; Chin-Yo Lin; Hwee Cheng Tan; Ai Ee Ling; Bing Lim; Lawrence W Stanton
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more
  6 in total

1.  Discovery of honokiol thioethers containing 1,3,4-oxadiazole moieties as potential α-glucosidase and SARS-CoV-2 entry inhibitors.

Authors:  Ting Xu; Jie-Ru Meng; Wanqing Cheng; Jia-Zheng Liu; Junyan Chu; Qian Zhang; Nannan Ma; Li-Ping Bai; Yong Guo
Journal:  Bioorg Med Chem       Date:  2022-05-21       Impact factor: 3.461

Review 2.  Antiviral Role of Phenolic Compounds against Dengue Virus: A Review.

Authors:  Vanessa Loaiza-Cano; Laura Milena Monsalve-Escudero; Carlos da Silva Maia Bezerra Filho; Marlen Martinez-Gutierrez; Damião Pergentino de Sousa
Journal:  Biomolecules       Date:  2020-12-24

3.  Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity.

Authors:  Zhongshun Liu; Congwei Jiang; Zhangmengxue Lei; Sihan Dong; Linlin Kuang; Chenxu Huang; Ying Gao; Mu Liu; Hui Xiao; Patrick Legembre; Jae U Jung; Huaping Liang; Xiaozhen Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 12.779

4.  Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection.

Authors:  Takashi Tanikawa; Tsuyoshi Hayashi; Ryuichiro Suzuki; Masashi Kitamura; Yutaka Inoue
Journal:  J Tradit Complement Med       Date:  2021-09-16

Review 5.  The application prospects of honokiol in dermatology.

Authors:  Yao Li; Chenglin Liang; Xiyuan Zhou
Journal:  Dermatol Ther       Date:  2022-06-28       Impact factor: 3.858

6.  Akt Kinase Intervenes in Flavivirus Replication by Interacting with Viral Protein NS5.

Authors:  Laura Albentosa-González; Nereida Jimenez de Oya; Armando Arias; Pilar Clemente-Casares; Miguel Ángel Martin-Acebes; Juan Carlos Saiz; Rosario Sabariegos; Antonio Mas
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.